TY  - GEN
AU  - Tamayo-Velasco, Álvaro
AU  - López-Herrero, Rocío
AU  - Gómez-García, Lara María
AU  - Sánchez-de Prada, Laura
AU  - Aguilar-Monserrate, Gerardo
AU  - Martín-Fernández, Marta
AU  - Bardají-Carrillo, Miguel
AU  - Álvaro-Meca, Alejandro
AU  - Tamayo, Eduardo
AU  - Resino, Salvador
AU  - Miramontes-González, José Pablo
AU  - Peñarrubia-Ponce, María Jesús
PY  - 2024
DO  - 10.1016/j.jiph.2024.04.005
UR  - http://hdl.handle.net/20.500.12105/19873
AB  - Background: COVID-19-associated pulmonary aspergillosis (CAPA) has emerged as a relatively common complication. Multiple studies described this relationship in critical patients, however its incidence and outcome in other risk groups such as...
LA  - eng
PB  - Elsevier
KW  - COVID-19-associated pulmonary aspergillosis  (CAPA)
KW  - Immunosuppressed infections, hematological patients
KW  - SARS-CoV-2
KW  - Fungal infections
KW  - Antifungal prophylaxis
KW  - COVID-19
KW  - COVID-19
KW  - Antifungal Agents
KW  - Hematologic Neoplasms
KW  - Invasive Pulmonary Aspergillosis
KW  - Humans
KW  - Male
KW  - Female
KW  - Retrospective Studies
KW  - Middle Aged
KW  - Aged
KW  - Spain
KW  - Adult
KW  - SARS-CoV-2
KW  - Pulmonary Aspergillosis
KW  - Risk Factors
KW  - Incidence
KW  - Immunocompromised Host
KW  - Hospitalization
TI  - COVID-19-associated pulmonary aspergillosis (CAPA) in hematological patients: Could antifungal prophylaxis be necessary? A nationwide study
TY  - research article
ER  -